Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Novella Launches Potent Whole-Cell Strawberry Ingredient at SSW


News provided by

Novella

Sep 16, 2025, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Novella Strawberry launches a new era of supplement innovation for peak potency, efficacy, and sustainability

MODI'IN, Israel, Sept. 16, 2025 /PRNewswire/ -- Biotech start-up Novella Innovative Technology, Ltd., an innovator in plant-cell-based ingredients, announces the launch of its Novella Strawberry, a patent-pending, new generation of bioactives derived from whole strawberry cells. This natural complex represents the first fruits of Novella's collection of fruit-cell nutraceutical solutions. This powerful ingredient sets a new standard for efficacy, bioavailability, and sustainability. The company will introduce Novella Strawberry at SupplySide West 2025 in Las Vegas, Booth #815.

Continue Reading
Novella Launches Potent Whole-Cell Strawberry Ingredient at SSW
Novella Launches Potent Whole-Cell Strawberry Ingredient at SSW

The AuraCell™ Platform

Leveraging its proprietary AuraCell™ technology, Novella has pioneered the precision cultivation of botanical ingredients, bypassing the need to grow the whole plant. The company cultivates valuable phytonutrients directly from the plant cells in a closed, controlled environment. The result is a pure, powerful bioactive ingredient with guaranteed consistency and zero waste, while slashing resource use by 99%, including water, land and labor.

Minimum dose, maximum impact

Unlike standard strawberry extracts that isolate a limited subset of compounds, Novella Strawberry is a whole-cell matrix that captures and preserves the full complexity of the fruit. This matrix delivers natural synergy and maximum performance in a reproducible format.

"We collect the high value nutrients from the strawberry at the peak of its power, grow them in a clean environment without pesticides, then amplify them," explains Shimrit Bar-El, Co-Founder and Chief Product Officer for Novella. "The result is a potent compound that can easily be absorbed in the body."

The innovative ingredient delivers an antioxidant punch up to 100 times stronger than conventional strawberry extracts, as demonstrated in human-cell assays conducted by Novella via measuring ROS inhibition. Novella Strawberry maintains the naturally occurring strawberry cell composition. This exceptional potency enables the use of significantly lower concentrations.

The strawberry challenge

In addition to their strong antioxidant power, strawberries contain a broad spectrum of bioactive compounds, including not only the well-known anthocyanins but also ellagic acid, phenolic acids, terpenoids, and alkaloids. While conventional products focus mainly on the anthocyanin group, the strawberry's much wider array of naturally occurring compounds remains underutilized. However, its unique richness has spurred a renewed growth of strawberries and other berries within the nutraceutical market, with rising demand in categories such as metabolism, weight management, beauty-from-within, and healthy ageing.

Despite its high wellness value and strong consumer interest, the integration of strawberry ingredients into supplements remains challenging. The poor stability of their bioactives makes it difficult to guarantee consistent and standardized dosing, while common industrial processing methods lead to significant nutrient loss.

Strawberries are highly climate sensitive. Their beneficial compounds degrade rapidly when exposed to heat, light, oxygen, and time. Moreover, agricultural production requires heavy irrigation and delivers variable yields of both fruit and its concentrated actives.

These limitations restrict strawberry extracts to complementary roles in supplements, driving shortages, low extraction yields, and higher costs. Novella's proprietary AuraCell™ technology directly addresses these challenges by cultivating intact strawberry cells in controlled environments free from seasonal constraints. It also unlocks broader applications across the nutraceutical and functional food industries.

"Our solution will significantly relieve the bottleneck in the nutraceutical industry's growing demand for strawberry-sourced nutrients while leaving field grown strawberries to be enjoyed as refreshing natural treats" informs Itay Dana, Co-Founder and Chief Business Development Officer for Novella.

Natural synergy

"Our AuraCell™ platform doesn't extract and doesn't need solvents" says Dana . "We preserve nature's full intelligence and deliver it intact. Novella Strawberry answers the consumer demand for performance and sustainability by delivering a holistic ingredient that is pure, potent, and generates zero waste."

The benefits of anthocyanins, the antioxidant flavonoid compounds commonly used in berry-based products, are typically acquired via digestion, microbial breakdown, and the variable gut environments. This leads to low, inconsistent bioavailability. Novella Strawberry delivers these phytochemicals and other fast-acting bioactives directly within plant cells. Novella' bioreactor-cultivated bioactives remain in their native cellular environment, acting as a form of natural microencapsulation. This shields sensitive compounds from oxidative stress and degradation within a formulation. It also preserves full-spectrum bioavailability and bioactivity while enabling them to work in synergy with other actives, enhancing their performance.

"Novella Strawberry is exactly what the next wave of dietary supplements needs," professes Dana. "It performs powerfully on its own, but its real potential is in enhancing other products—amplifying results while reducing required daily dose. It's a perfect marriage of science and strategy, with remarkable commercial potential."

With the growing demand for clean-label, high-performance, low-dose supplementation, Novella Strawberry empowers formulators and brands to enhance the value, and efficacy of their existing products, offering more to consumers without increasing complexity or cost. It is water-dispersible powder, making it ideal for powders, capsules, bars or beverages.

Novella recently announced its collaboration with Metaphor Foods in Australia for the inclusion of Novella products in Metaphor's line of preservatives. This showcases its robust antioxidant performance and impact beyond nutraceuticals into additional food categories.

Novella Strawberry will officially debut at SupplySide West 2025 in Las Vegas, Booth #815, in the new exhibitor zone where Novella will showcase its fruit-cell complexes and illustrate how its AuraCell™ platform is transforming the future of supplementation and wellness.

About Novella
Novella Innovative Technology, Ltd. is a biotechnology company pioneering fruit- and vegetable-derived cell complexes for clean, intelligent, and sustainable wellness solutions. Leveraging its proprietary AuraCell™ platform, Novella delivers intact plant-cell ingredients that preserve full-spectrum bioactivity, driving the next generation of supplement innovation.

For further information, please contact:

Company Contact:

Press Contact:

Novella Ltd.

Itay Dana

Co-founder and CBDO

NutriPR

Liat Simha

Tel: +972-9-974-2893

Email: [email protected]l

Web: www.novella.co.il

Email: [email protected]

Web: www.nutripr.com

Photo - https://mma.prnewswire.com/media/2772988/Novella_Launches_SSW.jpg

SOURCE Novella

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Novella and Metaphor Foods Unite to Commercialize Cell-Based Natural Preservatives

Novella and Metaphor Foods Unite to Commercialize Cell-Based Natural Preservatives

Biotech start-up Novella Innovative Technology, Ltd. and leading functional ingredient innovators Metaphor Foods, Braeside Victoria, Australia,...

More Releases From This Source

Explore

Retail

Retail

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Food & Beverages

Food & Beverages

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.